Open Access

Functional differentiation of midbrain neurons from human cord blood-derived induced pluripotent stem cells

  • Nancy Stanslowsky1, 2Email author,
  • Alexandra Haase3, 4,
  • Ulrich Martin3, 4,
  • Maximilian Naujock1, 2,
  • Andreas Leffler5,
  • Reinhard Dengler1, 2 and
  • Florian Wegner1, 2
Stem Cell Research & Therapy20145:35

DOI: 10.1186/scrt423

Received: 15 October 2013

Accepted: 11 March 2014

Published: 17 March 2014

Abstract

Introduction

Human induced pluripotent stem cells (hiPSCs) offer great promise for regenerative therapies or in vitro modelling of neurodegenerative disorders like Parkinson’s disease. Currently, widely used cell sources for the generation of hiPSCs are somatic cells obtained from aged individuals. However, a critical issue concerning the potential clinical use of these iPSCs is mutations that accumulate over lifetime and are transferred onto iPSCs during reprogramming which may influence the functionality of cells differentiated from them. The aim of our study was to establish a differentiation strategy to efficiently generate neurons including dopaminergic cells from human cord blood-derived iPSCs (hCBiPSCs) as a juvenescent cell source and prove their functional maturation in vitro.

Methods

The differentiation of hCBiPSCs was initiated by inhibition of transforming growth factor-β and bone morphogenetic protein signaling using the small molecules dorsomorphin and SB 431542 before final maturation was carried out. hCBiPSCs and differentiated neurons were characterized by immunocytochemistry and quantitative real time-polymerase chain reaction. Since functional investigations of hCBiPSC-derived neurons are indispensable prior to clinical applications, we performed detailed analysis of essential ion channel properties using whole-cell patch-clamp recordings and calcium imaging.

Results

A Sox1 and Pax6 positive neuronal progenitor cell population was efficiently induced from hCBiPSCs using a newly established differentiation protocol. Neuronal progenitor cells could be further maturated into dopaminergic neurons expressing tyrosine hydroxylase, the dopamine transporter and engrailed 1. Differentiated hCBiPSCs exhibited voltage-gated ion currents, were able to fire action potentials and displayed synaptic activity indicating synapse formation. Application of the neurotransmitters GABA, glutamate and acetylcholine induced depolarizing calcium signal changes in neuronal cells providing evidence for the excitatory effects of these ligand-gated ion channels during maturation in vitro.

Conclusions

This study demonstrates for the first time that hCBiPSCs can be used as a juvenescent cell source to generate a large number of functional neurons including dopaminergic cells which may serve for the development of novel regenerative treatment strategies.

Introduction

Human induced pluripotent stem cells (hiPSCs) derived from somatic cells hold great promise to study and treat neurodegenerative diseases. IPSCs are self-renewing and able to differentiate into neurons similarly to human embryonic stem cells (hESCs), but without the negative ethical connotation [13]. hiPSCs offer the advantage of providing an unlimited source of genetically personalized cells with a diminished risk of immunorejection, which seems attractive for regenerative cell therapies, such as the replacement of dopaminergic (DA) neurons in Parkinson’s disease [411]. Even though the functionality of neuronal cells generated in vitro is of high relevance for preclinical and clinical studies, investigation of the functional properties of hiPSCs-derived neurons is rare [1214].

In various studies somatic cells or stem cells from adult individuals were used to generate hiPSCs [1519]. The usage of juvenile rather than aged human cells for generation of iPSCs is expected to have the advantage of lacking genetic mutations that tend to accumulate in adult stem and somatic cells over a lifetime, contributing to aging processes and cancer formation [2022]. Although epigenetic reprogramming occurs and telomerase activity is restored during the process of pluripotency induction [23, 24], genomic and chromosomal abnormalities acquired in aged cells are not rectified and may influence the functionality of cells differentiated from those iPSCs. Besides their juvenile character, the utilization of human cord blood endothelial cells for the generation of iPSCs has further advantages. They can be easily collected without invasive procedures and the emergence of public and commercial cord blood banks predestines them for future clinical applications.

Over the last decade, various tissue culture protocols have emerged that recapitulate the DA differentiation process in hESCs and hiPSCs. Some approaches focused on stromal feeder cell co-cultures to promote DA differentiation [9, 11, 2535], others simply withdrew mitogens crucial for the maintenance of pluripotency to induce neuronal differentiation [6, 10, 3646]. Stromal feeder cells have the disadvantage of introducing greater variability in the differentiation process by secreting undefined factors. Although media components are defined in differentiation concepts in which mitogens were withdrawn, the signaling cascades leading to neural induction are not fully understood yet. Recently, the utilization of small molecule inhibitors of transforming growth factor-β (TGF-β) and bone morphogenetic protein (BMP) signaling in the differentiation process became more popular because they induce neural conversion in a defined manner and have been shown to enhance neural conversion efficiency by inhibiting mesenchymal differentiation [5, 31, 39, 4751]. In general, TGF-β/BMP ligands initiate signaling by phosphorylation of cytoplasmatic SMAD proteins upon receptor binding. Activated SMADs translocate to the nucleus where they regulate the transcription of target genes. The molecules dorsomorphin (DM) and SB 431542 (SB) antagonize the TGF-β and BMP pathways and, therefore, affect biological processes including neuronal patterning [52].

In this study, we show for the first time that iPSCs generated from human cord blood-derived endothelial cells by means of lentiviral overexpression of the four factors OCT4, SOX2, LIN28 and NANOG as described by Haase et al. [53] are able to differentiate into DA neurons by dual SMAD inhibition and exhibit functional neuronal properties. The differentiated neurons revealed large voltage-gated currents and were able to fire action potentials (APs). Spontaneous synaptic activity indicated the formation of synaptic connections. We demonstrated neurotransmitter-induced calcium transients providing evidence for ligand-gated receptor expression and excitatory GABA actions during maturation in vitro. These data suggest that human cord blood-derived iPSC (hCBiPSC)-derived neurons including dopaminergic cells develop essential functional properties and may deliver a juvenescent source for novel regenerative cell therapies.

Materials and methods

The use of human iPSCs in this study was approved by the local ethics committee of Hannover Medical School (Date: 08.07.2010, No. 776).

Human iPSC culture and in vitro differentiation

The hCBiPSC lines were generated and characterized by Haase et al. [53]. In brief, all cord blood endothelial cell isolates showed high expression of endothelial markers including CD31 and CD146 [53]. Lentiviral transductions with OCT4, SOX2, NANOG and LIN28 lead to reprogramming efficiencies of cord blood endothelial cells between 0.0001% and 0.03% [53]. The transplantation of undifferentiated hCBiPSCs into immunodeficient SCID-beige mice led to the formation of typical teratomas containing derivatives of all three germ layers [53]. Karyotype analyses revealed no abnormalities in the hCBiPSC clones [53].

Human CBiPSCs were expanded as described previously [53]. Undifferentiated hCBiPSCs were maintained on a feeder layer of mouse embryonic fibroblasts inactivated by gamma-irradiation (60 gray). Feeders were seeded at 1 × 105 cells/well in a six-well plate (Nunc, Langenselbold, Germany) coated with 1% gelatin (Sigma-Aldrich, Taufkirchen, Germany). If not otherwise stated all media and medium supplements were purchased from Life Technologies (Darmstadt, Germany). Cytokines were obtained from Peprotech (Hamburg, Germany).

For differentiation, hCBiPSC colonies were detached from the feeder layer and cultured in suspension as embryoid bodies (EBs) for four days in knockout medium containing knockout DMEM, 20% knockout serum replacement, 0.1 mM MEM nonessential amino acids, 2 mM glutamax and 0.1 mM β-mercaptoethanol supplemented with 10 μM SB 431542 (SB, Biomol, Hamburg, Germany) and 1 μM DM (R&D Systems, Wiesbaden-Nordenstadt, Germany). On day four, the medium was changed to DMEM/F12 consisting of glutamax, N2 supplement, 10 μM SB, 1 μM DM, 0.6 μM purmorphamine (PMA, Biomol) and 100 ng/ml fibroblast growth factor 8 (FGF8). After six days, SB and DM were withdrawn. After six additional days in suspension, EBs were attached to poly-L-ornithine (20 μg/ml)/laminin (10 μg/ml)-coated cell culture plates and cultured in Neurobasal medium supplemented with glutamax, N2, B27 minus AO, 20 ng/ml BDNF, 20 ng/ml GDNF, 25 ng/ml TGFβ3, 200 μM ascorbic acid (Sigma-Aldrich) and 1 mM cAMP (Sigma-Aldrich) for up to 30 days.

Immunocytochemistry

Cells were fixed in 4% paraformaldehyde and treated with blocking buffer (5% goat serum, 1% BSA, 0.3% Triton X-100 in PBS) for 45 minutes. Primary antibodies were applied overnight at 4°C. For visualization the appropriate fluorescence-labeled secondary antibodies were added for one hour at room temperature and nuclei were counterstained with 4’,6-diamidino-2-phenylindole (DAPI, 10 mg/ml, Life Technologies). The following primary antibodies were used: rabbit polyclonal anti-Oct4 (1:500, Cell Signaling, Danvers, Massachusetts, USA), mouse monoclonal anti-Pax6 (1:500, Millipore, Schwalbach, Germany), rabbit monoclonal anti-FoxA2 (1:250, Cell Signaling), mouse monoclonal anti-beta III tubulin (Tuj1, 1:500, Millipore), rabbit polyclonal anti-MAP2 (1:500, Millipore), rabbit polyclonal anti-TH (1:500, Santa Cruz Biotechnology, Heidelberg, Germany), rabbit polyclonal anti-GABA (1:1000, Sigma-Aldrich) and rabbit polyclonal anti-GFAP (1:500, Dako, Hamburg, Germany). Secondary antibodies were Alexa Fluor goat anti-mouse or anti-rabbit 488 or 555 (1:500, Life Technologies). All secondary antibodies were tested for specificity and cross reactivity.

Immunostainings were visualized by fluorescence microscopy (BX61; Olympus). Digital images were acquired with an Olympus DP72 camera using the image-analysis software CellF (Olympus). The number of cells immunoreactive for Tuj1, MAP2, TH, GABA or GFAP was determined related to the number of DAPI stained nuclei from at least three independent differentiation experiments. Approximately 1,000 cells were counted within three randomly selected visual fields.

Reverse transcription and quantitative real-time PCR

Total RNA was extracted using the RNeasy kit (Qiagen, Hilden, Germany) and treated with DNase I according to the manufacturers’ instructions. For each reaction, 1 μg of total RNA was reversely transcribed using oligo-dT primer and Superscript II reverse transcriptase (Life Technologies).

Quantitative real-time PCR experiments were performed with cDNA from 50 ng total RNA, 1.75 μM forward and reverse primer and Power SYBR-Green PCR Master Mix (Life Technologies) in a StepOnePlus instrument (Applied Biosystems, Darmstadt, Germany) under the following amplification conditions: 95°C for 10 minutes, followed by 40 cycles of 95°C for 15 seconds and 60°C for 1 minute. The specificity of the PCR products was ensured by melting curve analysis. The correct amplicon size was confirmed by agarose gel electrophoresis using a low molecular weight DNA ladder (New England Biolabs, Ipswich, MA, USA; see Additional file 1: Figure S1). Equal PCR efficiency of all primer pairs was validated by serial cDNA dilution. For primer information see Additional file 2: Table S1.

For the quantification of target gene expression the threshold cycle (Ct) values of the targets were normalized against that of the endogenous reference β2-microglobulin (Ct (target) – Ct (reference) = ΔCt). ΔCt values were plotted as relative levels of gene expression and are given as means ± standard error of the mean (SEM) from three differentiation experiments.

Electrophysiology

Patch pipettes were formed from borosilicate glass (Science Products, Hofheim, Germany) with a DMZ-universal puller (Zeitz-Instruments, Martinsried, Germany) and fire-polished to final resistances of 3 to 4 MΩ when filled with the internal solution consisting of 153 mM KCl, 1 mM MgCl2, 10 mM HEPES, 5 mM EGTA and 2 mM Mg-ATP, adjusted to pH 7.3 with KOH (305 mOsm). The bath solution contained 142 mM NaCl, 8 mM KCl, 1 mM CaCl2, 6 mM MgCl2, 10 mM glucose and 10 mM HEPES, adjusted to pH 7.4 with NaOH (325 mOsm). Tetrodotoxin (TTX, 1 μM), tetraethylammonium chloride (TEA, 10 mM), bicuculline (BIC, 10 μM) and 2,3-dihydroxy-6-nitro-7-sulphamoyl-benzo(f)quinoxaline (NBQX, 10 μM, all purchased from Sigma-Aldrich) were diluted in the bath solution and applied via gravity using a SF-77B perfusion fast-step system (Warner Instruments, Hamden, Connecticut, USA) as described previously [54]. The stock solution of BIC was dissolved in an external solution containing dimethyl sulfoxide (DMSO) at a maximal final concentration of 0.1%.

Whole-cell patch clamp experiments were performed at 20°C to 22°C under optical control (inverted microscope, Zeiss, Jena, Germany). Cells with leak currents <100 pA were used for further analysis. Whole-cell currents were low-pass filtered at 2.9 kHz, digitized at 10 kHz using an EPC-10 amplifier (HEKA, Lambrecht, Germany) and analyzed with Patch Master (HEKA).

Calcium imaging

Monitoring of cytosolic calcium transients in individual neurons was carried out using the membrane permeable fluorescent indicator Fura 2-AM (Sigma-Aldrich) in combination with the Till Vision Imaging System (T.I.L.L. Photonics, Gräfelfing, Germany) coupled to an upright microscope (Axioskop 2 FS plus, Zeiss). Emitted fluorescence was collected by a charge-coupled device (CCD) camera. Cultured cells were incubated for 30 minutes at 37°C with Fura 2-AM in a standard bath solution containing 140 mM NaCl, 5 mM KCl, 2 mM CaCl2, 10 mM glucose and 10 mM HEPES, adjusted to pH 7.4 with NaOH.

The intracellular Ca2+ was imaged by exciting Fura 2-AM at 340 and 380 nm with its emission monitored in intervals of 300 ms at 510 nm. Recordings were terminated by a 50 mM KCl stimulation to ensure the viability of the recorded cells. After background subtraction, the 340/380 nm excitation ratio for Fura 2-AM was calculated, which increases as a function of the cytosolic free Ca2+ concentration ([Ca2+]i). To determine [Ca2+]i a calibration measurement in the presence of 5 μM ionomycin or with a 10 mM EGTA solution free of Ca2+ was conducted. [Ca2+]i was calculated according to [Ca2+]i = β × KD(R ‒ Rmin)/(Rmax ‒ R) [55] with β = F380,max/F380,min = 3.6, KD = 245 nM, Rmin = 0.38 and Rmax = 1.6.

Statistics

Data were analyzed with GraphPad Prism (GraphPad Software, San Diego, CA, USA) by a two-way analysis of variance (ANOVA) and Bonferroni posttest or unpaired t-test as appropriate. All data are presented as means ± SEM and the significance level was set as P <0.05.

Results

Dorsomorphin, SB 431542, purmorphamine and FGF8 efficiently direct neural conversion and midbrain regionalization of hCBiPSCs

To explore the neuronal differentiation potential of hCBiPSCs in vitro, we evaluated four hCBiPSC lines generated by Haase et al. [53] by lentiviral transduction of the four pluripotency associated transcription factors OCT4, SOX2, NANOG and LIN28 into human cord blood-derived endothelial cells. All hCBiPSC lines exhibited morphological features typical for hESCs and expressed hESC markers [53]. Based on previous studies showing a highly efficient neuronal induction by dual inhibition of SMAD signaling using the small molecules DM and SB [48, 56], we first compared the efficiency of neural induction in our hCBiPSCs with and without SMAD inhibition by DM/SB during the first six days of differentiation. Already four days after the initiation of differentiation, the expression of the neural progenitor cell (NPC) markers Pax6 and Sox1 was significantly enhanced in cells treated with DM/SB (Figure 1A). Whereas the expression of Sox1 under DM/SB/PMA/FGF8 treatment was stable until 12 days of differentiation, the addition of PMA and FGF8 on day 4 reduced Pax6 expression to levels measured in untreated cells [57]. The loss of pluripotency during the maturation process monitored by Oct4 expression was comparable under both conditions (Figure 1B). After four days of differentiation, midbrain patterning was induced by addition of FGF8 and PMA, a small molecule known to be an effective substitute for sonic hedgehog [48, 58]. Foxa2 expression, as an early marker for midbrain regionalization, was significantly elevated from day 10 on in cells incubated with PMA/FGF8 for eight days (Figure 1B). These data suggest a reduction of pluripotency associated with a rapid and efficient differentiation towards neuroectoderm in DM/SB-treated cells and an efficient midbrain patterning induced by PMA and FGF8.
Figure 1

The utilization of dorsomorphin (DM) and SB 431542 (SB) in the hCBiPSCs differentiation process significantly improved neural conversion. Relative gene expression was measured by quantitative real-time PCR. (A) A marked increase in the expression of the neural stem cell markers Sox1 and Pax6 was observed during the first four days of differentiation by application of DM/SB (DIFF+) compared to cells differentiated without these molecules (DIFF-). (B) Downregulation of the pluripotency marker Oct4 was found as the maturation proceeded under both conditions. Midbrain regionalization, monitored by the expression of the midbrain marker FoxA2, was induced by PMA/FGF8 treatment (DIFF+) on day 4 of differentiation. A significantly higher FoxA2 level was observed in PMA/FGF8 treated cells compared to controls (DIFF-) from day 10 on. Values are calculated as means ± SEM. P-values (*P <0.05, **P <0.01, ***P <0.001) were determined using two-way ANOVA and Bonferroni posttest. ANOVA, analysis of variance; FGF8, fibroblast growth factor 8; hCBiPSCs, human cord blood induced pluripotent stem cells; PMA, purmorphamine; SEM, standard error of the mean.

hCBiPSCs differentiate into DA neurons in vitro

Figure 2A gives a schematic overview of the differentiation protocol used in this study. Figures 2B-F demonstrate representative light microscopic images of the neuronal maturation process. During expansion hCBiPSC colonies uniformly express the pluripotency marker Oct4 (Figure 2G). After six days of in vitro differentiation with DM/SB, Oct4-positive cells were rarely detected, whereas the vast majority of EBs were immunopositive for the NPC marker Pax6 (Figure 2H). On day 4, PMA and FGF8 were added to suspension cultures for eight days to induce midbrain regionalization. After 12 days in suspension, EBs were positive for the midbrain marker FoxA2 (Figure 2I). After plating onto PLO/Laminin-coated cell culture dishes, cells were cultured in the presence of BDNF, GDNF, TGFβ3, dbcAMP and ascorbic acid to promote terminal differentiation. Cells growing out of the EBs displayed immunoreactivity for the neuronal marker beta III tubulin (Tuj1; Figure 2J). After almost 40 days of in vitro differentiation 59 ± 3% of the cells were Tuj1+ and 17 ± 2% coexpressed the DA marker tyrosine hydroxylase (TH; Figure 2K, Figure 3C). Furthermore, 38 ± 5% GABAergic neurons were identified among the Tuj1+ cells (Figure 3D). The overall cell population contained 10 ± 1% TH+ neurons and 22 ± 3% GABA+ neurons. MAP2-staining, a marker for more mature neurons, showed reactivity in 42 ± 4% of the cells, whereby nearly all of these neurons were Tuj1+ as well (Figure 3A). Additionally, 14 ± 6% GFAP+ astrocytes were present in the cultures (Figure 3B). The vast majority of cells negative for Tuj1 or GFAP expressed the neural progenitor marker Sox1 (19 ± 7%), suggesting incomplete maturation. None of the cells were positive for the oligodendrocytic markers Olig2 and O4 (data not shown).
Figure 2

Sequential induction of hCBiPSCs towards dopaminergic neurons. (A) Schematic summary of the differentiation procedure. Phase-contrast images (B-F) and immunocytochemical stainings (G-K) during in vitro differentiation. Oct4-positive hCBiPSC colonies (B,G) were detached from the feeder layer and cultured in suspension as embryoid bodies (EBs) in the presence of dorsomorphin (DM) and SB 431542 (SB) for six days. During this time Oct4 expression was completely lost, whereas cells started to express the neural stem cell marker Pax6 (H). On day 4, purmorphamine (PMA) and FGF8 were added to initiate regionalization. After 12 days the vast majority of EBs coexpressed the midbrain marker FoxA2 (I). EBs were plated on PLO/laminin-coated cell culture dishes on day 12. Tuj1-positive neuronal cells spread out (J) and maturated into numerous dopaminergic (DA) neurons in the presence of BDNF, GDNF, TGFβ3, cAMP and ascorbic acid as indicated by tyrosine hydroxylase (TH)-positive cells (K). Scale bars represent 100 μm. FGF8, fibroblast growth factor 8; hCBiPSC, human cord blood induced pluripotent stem cells.

Figure 3

hCBiPSCs differentiated into dopaminergic and GABAergic neurons. (A, E) After 40 days of in vitro differentiation (40 DIV) almost 60% of the cells were positive for the neuronal marker beta III tubulin (Tuj1) and 40% showed reactivity against MAP2 indicating more mature neurons. A minor cell population of roughly 13% was positive for the astrocytic marker GFAP (B, E). Approximately 17% of Tuj1-positive cells were double labeled with antibodies against the dopaminergic marker tyrosine hydroxylase (TH, C, E) and nearly 40% were immunopositive for GABA (D, E). Scale bars represent 50 μm. Values are calculated as means ± SEM. hCBiPSC, human cord blood induced pluripotent stem cells; SEM, standard error of the mean.

qRT-PCR reveals midbrain DA patterning during in vitro differentiation

By qRT-PCR we investigated the genomic expression of several genes that are typically present in undifferentiated iPSCs, neural progenitors or differentiated DA neurons (Figure 4). Already four days after the beginning of differentiation the pluripotency marker Oct4 and Lin28, expressed in undifferentiated iPSCs, were markedly downregulated in most analyzed hCBiPSC lines (Figure 4A). Thereafter, we observed significant upregulation of transcription factors associated with the appearance of NPCs, for example, Sox1 and Pax6 (Figure 4B). These findings are consistent with the results of the immunocytochemical stainings (see above). In cultures subjected to 40 days of differentiation, we detected a significant elevation in mRNA expression for cell markers of mature midbrain DA neurons, for example, Tuj1, MAP2, TH, En1, and DAT in most of the cell lines (Figure 4C).
Figure 4

Quantitative real-time PCR of four hCBiPSC lines. Relative expression levels of pluripotency (A), neural progenitor (B) and neuronal and dopaminergic markers (C) in four hCBiPSC clones (K1, K2, K106, K120). (A) The expression of the pluripotency markers Oct4 and Lin28 is significantly decreased in most cell lines during expansion whereas the neural stem cell markers Sox1 and Pax6 (B) are markedly upregulated in all hCBiPSC clones after differentiation with DM/SB for four days. (C) After 40 days of differentiation in vitro the relative expression of the neuronal markers Tuj1 and MAP2 is significantly enhanced in almost all clones. Furthermore, the expression levels of tyrosine hydroxylase (TH) and the dopamine transporter (DAT) which are markers for dopaminergic neurons, as well as the mesencephalic marker engrailed 1 (En1) are significantly elevated in most cell lines. Results are reported as means ± SEM. P-values (*P <0.05, **P <0.01, ***P <0.001) were calculated using an unpaired t-test. Abbreviations: EXP, expanded cells; DIFF, differentiated cells. DM, dorsomorphin; hCBiPSC, human cord blood induced pluripotent stem cells; SEM, standard error of the mean.

Differentiated hCBiPSC-derived cells exhibit electrophysiological characteristics of functional neurons

Fundamental neuronal properties, such as excitability and synaptic transmission, are based on the functional expression of ion channel proteins. Therefore, we examined the electrophysiological properties of hCBiPSCs-derived neurons differentiated for six weeks in vitro. Voltage-gated sodium and potassium channels as well as action potential properties and synaptic activity were analyzed by whole-cell patch-clamp recordings. Large outward currents were reliably induced by depolarizing voltage steps of 10 mV from a holding potential of -70 mV to 40 mV. These currents showed voltage dependence and kinetics characteristic of potassium currents and were inhibited by the potassium channel blocker TEA (10 mM) applied to the extracellular solution (Figure 5A,C). In response to depolarization, 44% of the cells generated sodium inward currents that were blocked by the sodium channel blocker TTX (1 μM; Figure 5B,C). Peak currents were normalized for cell size based on the capacitance of the cell membrane (pA/pF, Figure 5C). In current-clamp experiments 39% (n = 7/18) of the neurons fired TTX-sensitive APs with average amplitudes of 51.2 ± 8.0 mV and durations of 3.2 ± 0.7 ms (Figure 5D). A summary of the functional properties of differentiated hCBiPSCs-derived neurons can be found in Table 1.
Figure 5

hCBiPSCs maturated into functional neurons in vitro . All functional analyses were conducted with the hCBiPSC line K2. (A-C) Voltage-activated sodium and potassium currents were recorded in the whole-cell voltage-clamp mode by increasing depolarizing steps of 10 mV from a holding potential of -70 to 40 mV. (A) Cells showed potassium outward currents (IK) that were inhibited by application of tetraethylammonium (TEA, 10 mM, n = 18). (B) Sodium inward currents (INa) could be completely blocked by tetrodotoxin (TTX, 1 μM, n = 8). (C) The current-voltage plot indicates the activation of IK between -30 and -20 mV. INa were activated between -40 and -20 mV with a current peak at -10 to 0 mV. Current amplitudes were normalized for cell capacitances and are calculated as means ± SEM. (D) Action potentials were elicited by a depolarizing current step of 100 pA in current-clamp mode and inhibited by application of 1 μM TTX (n = 7). Voltage-gated ion channel, passive membrane and action potential properties are summarized in Table 1. hCBiPSC, human cord blood induced pluripotent stem cells; SEM, standard error of the mean.

Table 1

Functional properties of hCBiPSC-K2 after differentiation for six weeks in vitro

Functional properties

Values of differentiated hCBiPSCs (n = 18)

Peak Na + -current

−859.1 ± 359.7 pA

Peak Na + -current/pF

−86.4 ± 31.7 pA/pF

Peak K + -current

1,034.2 ± 192.7 pA

Peak K + -current/pF

115.9 ± 20.8 pA/pF

Resting membrane potential

−34.4 ± 2.1 mV

Membrane capacitance

9.4 ± 1.1 pF

Input resistance

1,169.2 ± 389.7 MOhm

Cells with APs

7 (38.9%)

AP amplitude

51.2 ± 8.0 mV

AP duration

3.2 ± 0.7 ms

AHP amplitude

13.3 ± 3.0 mV

Time to peak AHP

10.6 ± 1.2 ms

Voltage-gated ion channel, passive membrane and action potential properties were determined by whole-cell patch clamp recordings. Data are given as means ± SEM. AP amplitude was measured from spike onset to peak, afterhyperpolarization (AHP) amplitude from peak to beginning of plateau reached during the current injection, AP duration was measured at half amplitude, and time to peak AHP from spike onset.

Another critical issue of neuronal functionality is the capability of hCBiPSC-derived neurons to form synaptic connections. This was explored by measuring spontaneous post-synaptic currents (PSCs) due to action potential-independent transmitter release, using the whole-cell voltage-clamp configuration at a holding potential of -70 mV. Spontaneous PSCs were measured in 40% of the cells showing an average frequency of 0.6 ± 0.2 Hz, which was reduced to 17.0 ± 12.6% by application of the GABAA receptor blocker bicuculline (BIC) (n = 5, Figure 6A and B). Inhibiting glutamatergic input by NBQX decreased the PSC frequency to only 74.5 ± 3.4%, indicating a predominantly GABAergic synaptic input. The mean amplitudes of spontaneous PSCs were 21.4 ± 3.7 pA.
Figure 6

Differentiated hCBiPSC exhibited spontaneous synaptic activity. (A) Current traces recorded in whole-cell voltage-clamp mode from a single cell of the hCBiPSC line K2 under control conditions (top) and following application of the AMPA receptor blocker NBQX (10 μM, middle) or the GABAA receptor blocker bicuculline (BIC, 10 μM, bottom). (B) Average frequency of spontaneous post-synaptic currents (PSCs). Application of BIC significantly reduced the PSC frequency to 17.0% (n = 5), NBQX just slightly depressed PSCs to 74.5% (n = 5). hCBiPSC, human cord blood induced pluripotent stem cells.

These data show that hCBiPSCs can give rise to functional neurons acquiring mature electrical properties and spontaneously active synaptic contacts during their differentiation in vitro.

Neurotransmitters induce increases in [Ca2+]i

The expression of functional ligand-gated channels in hCBiPSC-derived neurons was examined by measuring intracellular Ca2+ changes upon application of the neurotransmitters acetylcholine (ACh), GABA and glutamate in fura-2 loaded cells. Figure 7A shows typical neurons used during these experiments. For quantification of the intracellular Ca2+ concentration ([Ca2+]i) we performed calibration measurements. The basal Ca2+ level was RF340/F380 = 0.58, which corresponds to a basal [Ca2+]i of 100 ± 8 nM (n = 57 cells). Figure 7B illustrates Ca2+ traces of three representative cells upon stimulation by ACh, GABA and glutamate as well as the depolarizing agent KCl. The excitatory neurotransmitter ACh and glutamate induced an increase in intracellular Ca2+ in 25 ± 8% and 22 ± 18% of the cells, respectively (Figure 7C). GABA, as the most prominent inhibitory neurotransmitter in the adult central nervous system (CNS), induced a Ca2+ response in 62 ± 2% of the cells suggesting depolarizing excitatory GABA-effects in most neurons. Ca2+ responses to KCl application were shown by 68 ± 4% of the cells indicating the neuronal population. On average, the application of ACh led to an increase of the fluorescent signal of RF340/F380 = 0.10 ± 0.01, which correlates to an increase in cytosolic Ca2+ of 117 ± 17 nM (Figure 7D). GABA induced a [Ca2+]i rise of 142 ± 12 nM and glutamate application resulted in a [Ca2+]i boost of 76 ± 20 nM. KCl as a depolarizing agent leading to the activation of voltage-dependent calcium channels induced the highest Ca2+ response of 170 ± 20 nM and indicated the viability of cells at the end of each measurement. Our data show that hCBiPSC-derived neurons develop functional ACh, GABA and glutamate receptors during differentiation in vitro.
Figure 7

Differentiated hCBiPSCs showed KCl- and neurotransmitter-mediated Ca 2+ signaling. (A) hCBiPSC-K2 were loaded with Fura-2 after four weeks of differentiation in vitro. (B) Transient cytosolic Ca2+ changes of three representative cells induced by bath application of acetylcholine (ACh, 100 μM), GABA (100 μM), glutamate (50 μM) and KCl (50 mM). Intracellular calcium concentrations are presented as ratios of the fluorescence signals obtained at 340 and 380 nm (F340/F380). (C) Fractions of cells responding to ACh (25%), GABA (62%), glutamate (22%) and KCl (68%) obtained from experiments as shown in (B). (D) Summary of cytosolic Ca2+ response amplitudes given as ratio F340/F380 (left) and intracellular calcium concentration ([Ca2+]i, right) both normalized to the basal calcium level of the cells. Basal intracellular Ca2+ level was 100 ± 8 nM (n = 57 cells). Note, GABA induced depolarizing effects in most investigated cells. All data are given as mean ± SEM. hCBiPSC, human cord blood induced pluripotent stem cells; SEM, standard error of the mean.

Discussion

We demonstrated the ability of iPSCs generated from human cord blood endothelial cells [53] to be directed to a neuronal cell fate similar to hiPSC lines obtained from adult somatic cell sources. The small molecules DM and SB, that have been shown to rapidly induce neuralization in hESCs and hiPSCs by dual inhibition of TGF-β/BMP signaling [48, 51, 56, 59, 60], were able to enhance neural conversion efficiency in our hCBiPSC cultures as well. DM, an antagonist of the BMP pathway, selectively blocks the BMP type I receptors ALK2, ALK3 and ALK6, and thereby inhibits downstream SMAD1/5/8 signaling [48, 50, 61]. SB is a selective blocker of the TGF-β/activin pathway. It targets activin receptor-like kinase receptors ALK4, ALK5 and ALK7, leading to inhibition of SMAD2/3 signaling [49, 56, 59, 60, 62, 63]. The synergistic block of both signaling cascades retards differentiation towards endoderm, mesoderm and trophoectoderm and facilitates neuroectodermal differentiation as suggested by gene expression analysis and immunostainings for neural precursor markers [48, 51].

The percentage of Tuj1-positive neurons achieved in this study by dual SMAD inhibition was approximately 60%. To our knowledge, there are only two studies using the same combination of small molecules (DM/SB) for neural conversion of hiPSCs from adult skin fibroblasts [48, 56]. Mak and colleagues [48] reported 86% Tuj1+ neurons and 9% TH+/Tuj1+ cells after enrichment of NPCs via microbeads. We achieved a nearly twofold amount of TH+/Tuj+ cells (17%). Further publications performing SMAD inhibition with noggin, another BMP antagonist, instead of DM or with additional stimulation of WNT signaling [13, 51, 64, 65] obtained neuronal differentiation efficiencies of fibroblast-derived hiPSCs ranging from 17% to 70% Tuj1+ cells. The newest approach skipping the iPSC intermediate stage and directly reprogramming human fibroblasts to neurons yielded only 10% to 16% Tuj1+ cells [66, 67]. In relation to those results, our culturing strategy resulted in more efficient neurogenesis. The reasons for the heterogeneity in the differentiation capacity of different iPSC lines are not fully understood yet. There are slight variations of gene expression possibly due to differential promoter binding by the reprogramming factors [12, 68, 69] or epigenetical reasons [70]. Hirose et al. [71] discussed that the initial culture conditions for maintaining the undifferentiated state strongly influence the differentiation propensity. The percentage of TH+ DA neurons was consistent with most of the previous results from other research groups, reporting between 3% to 30% TH+ cells per total cells from fibroblast-derived hiPSCs or directly reprogrammed human fibroblasts [6, 10, 12, 43, 6567]. Higher percentages of TH+/Tuj1+ neurons (35% to 65%) could only be achieved by overexpression of developmental transcription factor, for example, LMX1A either alone or in combination with ASCL1 and NURR1, or by co-culturing on stromal feeder cells [9, 64, 72, 73].

It is even more important that neurons generated from hiPSCs are functional rather than just exhibiting a neuronal morphology and gene expression pattern. The number of studies dealing with functional properties of neurons generated from hiPSCs is currently quite limited [1214, 51, 70]. While most studies show a few neuronal features, we conducted a detailed analysis on voltage- and ligand-gated ion channels. Our data demonstrate the maturation of neuronal function in hCBiPSCs-derived cells after in vitro differentiation. Previous approaches to characterize fibroblast-derived hiPSCs elucidated that differentiated cells possessed voltage-gated current amplitudes of INa -195 pA/pF and IK 208 pA/pF and were able to generate multiple APs [12]. The currents we measured displayed somewhat smaller mean amplitudes of INa -86 pA/pF and IK 116pA/pF which were comparable to those seen in neurons directly reprogrammed from human fibroblasts [66]. Also, trains of APs or spontaneous firing as reported from some research groups [13, 74] were absent in our hCBiPSCs-derived neurons suggesting a yet incomplete neuronal maturation after 40 days of differentiation. This is in line with the recorded resting membrane potential of -34 mV, which is slightly below the values (-39 to -58 mV) that had been reported for hESC-derived neurons or neurons generated directly from human fibroblasts [44, 66, 67, 74]. The percentage of cells with inducible APs strongly varies among several publications. We recorded nearly 40% neurons with APs, Stover et al. [14] observed just 14%, whereas Zeng and colleagues [12] obtained 75% firing cells. However, we were not able to yield as high percentages of cells (50% to 100%) with inducible APs as studies using hESCs [74] or methods to directly convert fibroblast to DA neurons (71% to 83%; [66, 67]). The AP amplitudes of 51 mV on the other hand were similar to previous observations for hiPSC-derived neurons (50 mV [12]) and within the range of studies with hESC-derived nerve cells (35 to 50 mV [74]; 32 mV [44]; 74 to 84 mV [60]) and direct reprogrammed fibroblasts (approximately 45 mV [67]; 78 mV [66]). AP durations (3 ms) were also in the reported range of 1 to 7 ms [44, 60, 66, 67, 74]. Whether prolonged in vitro differentiation can give rise to fully mature hCBiPSC-derived neurons or if in vivo maturation will be required, as shown by Wernig et al. [75], remains to be investigated.

Measuring spontaneous PSCs as a sign of synaptic connectivity in neuronal systems revealed that 40% of differentiated cells exhibited spontaneous activity. This is consistent with the work of Johnson et al. [74], observing maximal 50% of neurons with PSCs among differentiating hESCs regardless of the maturation period. Schaarschmidt et al. [76] reported 94% of neurons differentiated from human fetal NPCs to receive synaptic input. Interestingly, Johnson et al. [74] found that the onset of synaptic activity is associated with the outgrowth of astrocytes in their cultures. Likewise, multiple other studies have shown that co-cultivating neurons with astrocytes enhances synaptogenesis [7779]. Thus, the disparity between the results could possibly be attributed to the number of astrocytes in the cultures. While we had 14% GFAP+ cells after differentiation, Schaarschmidt and colleagues [76] reported more than 30%.

To our knowledge, we are the first group investigating ligand-gated ion channels in differentiated neurons from hiPSCs at all. We found that Ca2+ transients in differentiated hCBiPSCs rose in a less pronounced fashion and in a fewer percentage of cells (22%) when glutamate receptors were stimulated, compared to studies with differentiated human fetal NPCs (>95%) [80]. On the other hand, during application of GABA more cells (62%) responded with higher Ca2+ amplitudes in comparison with differentiated fetal NPCs (48%) [81]. The calcium imaging results confirm our electrophysiological data indicating a not yet fully mature neuronal phenotype. This assumption is supported by the excitatory action of GABA in differentiated hCBiPSCs. The ability of GABA to depolarize cells depends on the intracellular Cl concentration. If the Cl importer NKCC1 is expressed more pronounced than the Cl exporter KCC2, as it is in the prenatal state of development, the intracellular Cl concentration is high and GABA has a depolarizing effect, because of a Cl efflux [82, 83]. Nevertheless, we were able to show that hCBiPSC-derived neurons exhibit functional ligand-gated ion channels during their maturation in vitro.

Given their easy accessibility and low immunogenicity, the interest in using iPSCs for regenerative cell therapy is high. Animal studies have shown that iPSC-derived neurons survive and integrate into the host brain and are able to reduce motor symptoms in parkinsonian animal models [6, 9, 10, 64, 75]. However, several critical issues such as graft survival and overgrowth or tumor formation remain obstacles to further preclinical studies. It will have to be determined if the usage of juvenescent rather than adult human cells for the derivation of iPSCs may help to overcome these problems.

Conclusions

Our data indicate the successful and highly efficient in vitro generation of hCBiPSC-derived neurons including dopaminergic cells. We provide a detailed functional analysis of voltage- and ligand-gated ion channels which is a prerequisite for clinical applications. Our hCBiPSC-derived neurons exhibit essential functional properties and may serve as a juvenescent cell source for the development of novel regenerative treatment strategies.

Abbreviations

(D)MEM: 

(Dulbecco’s) modified Eagle’s medium

Ach: 

acetylcholine

AHP: 

afterhyperpolarization

AP: 

action potential

BIC: 

bicuculline

BMP: 

bone morphogenetic protein

BSA: 

bovine serum albumin

DA: 

dopamine

DA: 

dopamine

DAT: 

dopamine transporter

DM: 

dorsomorphin

EBs: 

embryoid bodies

FGF: 

fibroblast growth factor

hCBiPSCs: 

human cord blood endothelial cell-derived induced pluripotent stem cells

hESCs: 

human embryonic stem cells

NPCs: 

neuronal progenitor cells

PBS: 

phosphate-buffered saline

PMA: 

purmorphamine

PSC: 

postsynaptic currents

SEM: 

standard error of the mean

TEA: 

tetraethylammonium chloride

TGF-β: 

transforming growth factor-β

TH: 

tyrosine hydroxylase

TTX: 

tetrodotoxin.

Declarations

Acknowledgements

The authors thank Carola Kassebaum and Andreas Niesel for excellent technical assistance. Prof. Dr. Thomas Scheper (Leibniz University of Hannover) kindly provided human FGF-2. We thank Prof. Dr. Helge Frieling (Hannover Medical School) for granting us access to their NanoDrop spectrophotometer.

Authors’ Affiliations

(1)
Department of Neurology, Hannover Medical School
(2)
Center for Systems Neuroscience
(3)
Department of Cardiac, Thoracic, Transplantation, and Vascular Surgery, Leibnitz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Hannover Medical School
(4)
REBIRTH-Cluster of Excellence
(5)
Department of Anaesthesia and Critical Care Medicine, Hannover Medical School

References

  1. Boer GJ: Ethical issues in neurografting of human embryonic cells. Theor Med Bioeth. 1999, 20: 461-475. 10.1023/A:1009985223158.View ArticlePubMedGoogle Scholar
  2. Okita K, Ichisaka T, Yamanaka S: Generation of germline-competent induced pluripotent stem cells. Nature. 2007, 448: 313-317. 10.1038/nature05934.View ArticlePubMedGoogle Scholar
  3. Boland MJ, Hazen JL, Nazor KL, Rodriguez AR, Gifford W, Martin G, Kupriyanov S, Baldwin KK: Adult mice generated from induced pluripotent stem cells. Nature. 2009, 461: 91-94. 10.1038/nature08310.View ArticlePubMedGoogle Scholar
  4. Bjorklund LM, Sanchez-Pernaute R, Chung S, Andersson T, Chen IY, McNaught KS, Brownell AL, Jenkins BG, Wahlestedt C, Kim KS, Isacson O: Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A. 2002, 99: 2344-2349. 10.1073/pnas.022438099.PubMed CentralView ArticlePubMedGoogle Scholar
  5. Kim DS, Lee JS, Leem JW, Huh YJ, Kim JY, Kim HS, Park IH, Daley GQ, Hwang DY, Kim DW: Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity. Stem Cell Rev. 2010, 6: 270-281. 10.1007/s12015-010-9138-1.View ArticlePubMedGoogle Scholar
  6. Cai J, Yang M, Poremsky E, Kidd S, Schneider JS, Iacovitti L: Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats. Stem Cells Dev. 2010, 19: 1017-1023. 10.1089/scd.2009.0319.PubMed CentralView ArticlePubMedGoogle Scholar
  7. Lindvall O, Bjorklund A: Cell therapy in Parkinson’s disease. NeuroRx. 2004, 1: 382-393. 10.1602/neurorx.1.4.382.PubMed CentralView ArticlePubMedGoogle Scholar
  8. Kriks S, Shim JW, Piao J, Ganat YM, Wakeman DR, Xie Z, Carrillo-Reid L, Auyeung G, Antonacci C, Buch A, Yang L, Beal MF, Surmeier DJ, Kordower JH, Tabar V, Studer L: Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease. Nature. 2011, 480: 547-551.PubMed CentralPubMedGoogle Scholar
  9. Rhee YH, Ko JY, Chang MY, Yi SH, Kim D, Kim CH, Shim JW, Jo AY, Kim BW, Lee H, Lee SH, Suh W, Park CH, Koh HC, Lee YS, Lanza R, Kim KS, Lee SH: Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease. J Clin Invest. 2011, 121: 2326-2335. 10.1172/JCI45794.PubMed CentralView ArticlePubMedGoogle Scholar
  10. Swistowski A, Peng J, Liu Q, Mali P, Rao MS, Cheng L, Zeng X: Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. Stem Cells. 2010, 28: 1893-1904. 10.1002/stem.499.PubMed CentralView ArticlePubMedGoogle Scholar
  11. Ben-Hur T, Idelson M, Khaner H, Pera M, Reinhartz E, Itzik A, Reubinoff BE: Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats. Stem Cells. 2004, 22: 1246-1255. 10.1634/stemcells.2004-0094.View ArticlePubMedGoogle Scholar
  12. Zeng H, Guo M, Martins-Taylor K, Wang X, Zhang Z, Park JW, Zhan S, Kronenberg MS, Lichtler A, Liu HX, Chen FP, Yue L, Li XJ, Xu RH: Specification of region-specific neurons including forebrain glutamatergic neurons from human induced pluripotent stem cells. PLoS One. 2010, 5: e11853-10.1371/journal.pone.0011853.PubMed CentralView ArticlePubMedGoogle Scholar
  13. Shi Y, Kirwan P, Smith J, Robinson HP, Livesey FJ: Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses. Nat Neurosci. 2012, 15: 477-486. 10.1038/nn.3041. S471View ArticlePubMedGoogle Scholar
  14. Stover AE, Brick DJ, Nethercott HE, Banuelos MG, Sun L, O’Dowd DK, Schwartz PH: Process-based expansion and neural differentiation of human pluripotent stem cells for transplantation and disease modeling. J Neurosci Res. 2013, 91: 1247-1262. 10.1002/jnr.23245.PubMed CentralView ArticlePubMedGoogle Scholar
  15. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA: Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007, 318: 1917-1920. 10.1126/science.1151526.View ArticlePubMedGoogle Scholar
  16. Liu H, Ye Z, Kim Y, Sharkis S, Jang YY: Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes. Hepatology. 2010, 51: 1810-1819. 10.1002/hep.23626.PubMed CentralView ArticlePubMedGoogle Scholar
  17. Loh YH, Agarwal S, Park IH, Urbach A, Huo H, Heffner GC, Kim K, Miller JD, Ng K, Daley GQ: Generation of induced pluripotent stem cells from human blood. Blood. 2009, 113: 5476-5479. 10.1182/blood-2009-02-204800.PubMed CentralView ArticlePubMedGoogle Scholar
  18. Lowry WE, Richter L, Yachechko R, Pyle AD, Tchieu J, Sridharan R, Clark AT, Plath K: Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A. 2008, 105: 2883-2888. 10.1073/pnas.0711983105.PubMed CentralView ArticlePubMedGoogle Scholar
  19. Narsinh KH, Jia F, Robbins RC, Kay MA, Longaker MT, Wu JC: Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors. Nat Protoc. 2011, 6: 78-88.PubMed CentralView ArticlePubMedGoogle Scholar
  20. Kennedy SR, Loeb LA, Herr AJ: Somatic mutations in aging, cancer and neurodegeneration. Mech Ageing Dev. 2012, 133: 118-126. 10.1016/j.mad.2011.10.009.PubMed CentralView ArticlePubMedGoogle Scholar
  21. Ono T, Uehara Y, Saito Y, Ikehata H: Mutation theory of aging, assessed in transgenic mice and knockout mice. Mech Ageing Dev. 2002, 123: 1543-1552. 10.1016/S0047-6374(02)00090-8.View ArticlePubMedGoogle Scholar
  22. Trifunovic A, Larsson NG: Mitochondrial dysfunction as a cause of ageing. J Intern Med. 2008, 263: 167-178. 10.1111/j.1365-2796.2007.01905.x.View ArticlePubMedGoogle Scholar
  23. Marion RM, Strati K, Li H, Tejera A, Schoeftner S, Ortega S, Serrano M, Blasco MA: Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell. 2009, 4: 141-154. 10.1016/j.stem.2008.12.010.View ArticlePubMedGoogle Scholar
  24. Yehezkel S, Rebibo-Sabbah A, Segev Y, Tzukerman M, Shaked R, Huber I, Gepstein L, Skorecki K, Selig S: Reprogramming of telomeric regions during the generation of human induced pluripotent stem cells and subsequent differentiation into fibroblast-like derivatives. Epigenetics. 2011, 6: 63-75. 10.4161/epi.6.1.13390.PubMed CentralView ArticlePubMedGoogle Scholar
  25. Perrier AL, Tabar V, Barberi T, Rubio ME, Bruses J, Topf N, Harrison NL, Studer L: Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A. 2004, 101: 12543-12548. 10.1073/pnas.0404700101.PubMed CentralView ArticlePubMedGoogle Scholar
  26. Buytaert-Hoefen KA, Alvarez E, Freed CR: Generation of tyrosine hydroxylase positive neurons from human embryonic stem cells after coculture with cellular substrates and exposure to GDNF. Stem Cells. 2004, 22: 669-674. 10.1634/stemcells.22-5-669.View ArticlePubMedGoogle Scholar
  27. Cooper O, Hargus G, Deleidi M, Blak A, Osborn T, Marlow E, Lee K, Levy A, Perez-Torres E, Yow A, Isacson O: Differentiation of human ES and Parkinson’s disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid. Mol Cell Neurosci. 2010, 45: 258-266. 10.1016/j.mcn.2010.06.017.PubMed CentralView ArticlePubMedGoogle Scholar
  28. Ko JY, Park CH, Koh HC, Cho YH, Kyhm JH, Kim YS, Lee I, Lee YS, Lee SH: Human embryonic stem cell-derived neural precursors as a continuous, stable, and on-demand source for human dopamine neurons. J Neurochem. 2007, 103: 1417-1429. 10.1111/j.1471-4159.2007.04898.x.View ArticlePubMedGoogle Scholar
  29. Martinat C, Bacci JJ, Leete T, Kim J, Vanti WB, Newman AH, Cha JH, Gether U, Wang H, Abeliovich A: Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype. Proc Natl Acad Sci U S A. 2006, 103: 2874-2879. 10.1073/pnas.0511153103.PubMed CentralView ArticlePubMedGoogle Scholar
  30. Park CH, Minn YK, Lee JY, Choi DH, Chang MY, Shim JW, Ko JY, Koh HC, Kang MJ, Kang JS, Rhie DJ, Lee YS, Son H, Moon SY, Kim KS, Lee SH: In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neurons. J Neurochem. 2005, 92: 1265-1276. 10.1111/j.1471-4159.2004.03006.x.View ArticlePubMedGoogle Scholar
  31. Sonntag KC, Pruszak J, Yoshizaki T, van Arensbergen J, Sanchez-Pernaute R, Isacson O: Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin. Stem Cells. 2007, 25: 411-418. 10.1634/stemcells.2006-0380.PubMed CentralView ArticlePubMedGoogle Scholar
  32. Zeng X, Cai J, Chen J, Luo Y, You ZB, Fotter E, Wang Y, Harvey B, Miura T, Backman C, Chen GJ, Rao MS, Freed WJ: Dopaminergic differentiation of human embryonic stem cells. Stem Cells. 2004, 22: 925-940. 10.1634/stemcells.22-6-925.View ArticlePubMedGoogle Scholar
  33. Lee G, Kim H, Elkabetz Y, Al Shamy G, Panagiotakos G, Barberi T, Tabar V, Studer L: Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. Nat Biotechnol. 2007, 25: 1468-1475.View ArticlePubMedGoogle Scholar
  34. Kawasaki H, Mizuseki K, Nishikawa S, Kaneko S, Kuwana Y, Nakanishi S, Nishikawa SI, Sasai Y: Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron. 2000, 28: 31-40. 10.1016/S0896-6273(00)00083-0.View ArticlePubMedGoogle Scholar
  35. Vazin T, Chen J, Lee CT, Amable R, Freed WJ: Assessment of stromal-derived inducing activity in the generation of dopaminergic neurons from human embryonic stem cells. Stem Cells. 2008, 26: 1517-1525. 10.1634/stemcells.2008-0039.PubMed CentralView ArticlePubMedGoogle Scholar
  36. Lee SH, Lumelsky N, Studer L, Auerbach JM, McKay RD: Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol. 2000, 18: 675-679. 10.1038/76536.View ArticlePubMedGoogle Scholar
  37. Cho MS, Lee YE, Kim JY, Chung S, Cho YH, Kim DS, Kang SM, Lee H, Kim MH, Kim JH, Leem JW, Oh SK, Choi YM, Hwang DY, Chang JW, Kim DW: Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A. 2008, 105: 3392-3397. 10.1073/pnas.0712359105.PubMed CentralView ArticlePubMedGoogle Scholar
  38. Geeta R, Ramnath RL, Rao HS, Chandra V: One year survival and significant reversal of motor deficits in parkinsonian rats transplanted with hESC derived dopaminergic neurons. Biochem Biophys Res Commun. 2008, 373: 258-264. 10.1016/j.bbrc.2008.06.022.View ArticlePubMedGoogle Scholar
  39. Iacovitti L, Donaldson AE, Marshall CE, Suon S, Yang M: A protocol for the differentiation of human embryonic stem cells into dopaminergic neurons using only chemically defined human additives: studies in vitro and in vivo. Brain Res. 2007, 1127: 19-25.PubMed CentralView ArticlePubMedGoogle Scholar
  40. Ma L, Liu Y, Zhang SC: Directed differentiation of dopamine neurons from human pluripotent stem cells. Methods Mol Biol. 2011, 767: 411-418. 10.1007/978-1-61779-201-4_30.View ArticlePubMedGoogle Scholar
  41. Roy NS, Cleren C, Singh SK, Yang L, Beal MF, Goldman SA: Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med. 2006, 12: 1259-1268. 10.1038/nm1495.View ArticlePubMedGoogle Scholar
  42. Schulz TC, Noggle SA, Palmarini GM, Weiler DA, Lyons IG, Pensa KA, Meedeniya AC, Davidson BP, Lambert NA, Condie BG: Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture. Stem Cells. 2004, 22: 1218-1238. 10.1634/stemcells.2004-0114.View ArticlePubMedGoogle Scholar
  43. Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, Hargus G, Blak A, Cooper O, Mitalipova M, Isacson O, Jaenisch R: Parkinson’s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell. 2009, 136: 964-977. 10.1016/j.cell.2009.02.013.PubMed CentralView ArticlePubMedGoogle Scholar
  44. Yan Y, Yang D, Zarnowska ED, Du Z, Werbel B, Valliere C, Pearce RA, Thomson JA, Zhang SC: Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells. 2005, 23: 781-790. 10.1634/stemcells.2004-0365.PubMed CentralView ArticlePubMedGoogle Scholar
  45. Zhang SC, Wernig M, Duncan ID, Brustle O, Thomson JA: In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol. 2001, 19: 1129-1133. 10.1038/nbt1201-1129.View ArticlePubMedGoogle Scholar
  46. Schuldiner M, Eiges R, Eden A, Yanuka O, Itskovitz-Eldor J, Goldstein RS, Benvenisty N: Induced neuronal differentiation of human embryonic stem cells. Brain Res. 2001, 913: 201-205. 10.1016/S0006-8993(01)02776-7.View ArticlePubMedGoogle Scholar
  47. Gerrard L, Rodgers L, Cui W: Differentiation of human embryonic stem cells to neural lineages in adherent culture by blocking bone morphogenetic protein signaling. Stem Cells. 2005, 23: 1234-1241. 10.1634/stemcells.2005-0110.View ArticlePubMedGoogle Scholar
  48. Mak SK, Huang YA, Iranmanesh S, Vangipuram M, Sundararajan R, Nguyen L, Langston JW, Schule B: Small molecules greatly improve conversion of human-induced pluripotent stem cells to the neuronal lineage. Stem Cells Int. 2012, 2012: 140427-PubMed CentralView ArticlePubMedGoogle Scholar
  49. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L: Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol. 2009, 27: 275-280. 10.1038/nbt.1529.PubMed CentralView ArticlePubMedGoogle Scholar
  50. Zhou J, Su P, Li D, Tsang S, Duan E, Wang F: High-efficiency induction of neural conversion in human ESCs and human induced pluripotent stem cells with a single chemical inhibitor of transforming growth factor beta superfamily receptors. Stem Cells. 2010, 28: 1741-1750. 10.1002/stem.504.PubMed CentralView ArticlePubMedGoogle Scholar
  51. Reinhardt P, Glatza M, Hemmer K, Tsytsyura Y, Thiel CS, Hoing S, Moritz S, Parga JA, Wagner L, Bruder JM, Wu G, Schmid B, Röpke A, Klingauf J, Schwamborn JC, Gasser T, Schöler HR, Sterneckert J: Derivation and expansion using only small molecules of human neural progenitors for neurodegenerative disease modeling. PLoS One. 2013, 8: e59252-10.1371/journal.pone.0059252.PubMed CentralView ArticlePubMedGoogle Scholar
  52. Herpin A, Cunningham C: Cross-talk between the bone morphogenetic protein pathway and other major signaling pathways results in tightly regulated cell-specific outcomes. FEBS J. 2007, 274: 2977-2985. 10.1111/j.1742-4658.2007.05840.x.View ArticlePubMedGoogle Scholar
  53. Haase A, Olmer R, Schwanke K, Wunderlich S, Merkert S, Hess C, Zweigerdt R, Gruh I, Meyer J, Wagner S, Maier LS, Han DW, Glage S, Miller K, Fischer P, Schöler HR, Martin U: Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell. 2009, 5: 434-441. 10.1016/j.stem.2009.08.021.View ArticlePubMedGoogle Scholar
  54. Wegner F, Deuther-Conrad W, Scheunemann M, Brust P, Fischer S, Hiller A, Diekers M, Strecker K, Wohlfarth K, Allgaier C, Steinbach J, Hoepping A: GABAA receptor pharmacology of fluorinated derivatives of the novel sedative-hypnotic pyrazolopyrimidine indiplon. Eur J Pharmacol. 2008, 580: 1-11. 10.1016/j.ejphar.2007.10.016.View ArticlePubMedGoogle Scholar
  55. Grynkiewicz G, Poenie M, Tsien RY: A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985, 260: 3440-3450.PubMedGoogle Scholar
  56. Morizane A, Doi D, Kikuchi T, Nishimura K, Takahashi J: Small-molecule inhibitors of bone morphogenic protein and activin/nodal signals promote highly efficient neural induction from human pluripotent stem cells. J Neurosci Res. 2011, 89: 117-126. 10.1002/jnr.22547.View ArticlePubMedGoogle Scholar
  57. Nat R, Salti A, Suciu L, Strom S, Dechant G: Pharmacological modulation of the Hedgehog pathway differentially affects dorsal/ventral patterning in mouse and human embryonic stem cell models of telencephalic development. Stem Cells Dev. 2012, 21: 1016-1046. 10.1089/scd.2011.0271.View ArticlePubMedGoogle Scholar
  58. Sinha S, Chen JK: Purmorphamine activates the Hedgehog pathway by targeting Smoothened. Nat Chem Biol. 2006, 2: 29-30. 10.1038/nchembio753.View ArticlePubMedGoogle Scholar
  59. Cai J, Schleidt S, Pelta-Heller J, Hutchings D, Cannarsa G, Iacovitti L: BMP and TGF-beta pathway mediators are critical upstream regulators of Wnt signaling during midbrain dopamine differentiation in human pluripotent stem cells. Dev Biol. 2013, 376: 62-73. 10.1016/j.ydbio.2013.01.012.PubMed CentralView ArticlePubMedGoogle Scholar
  60. Drury-Stewart D, Song M, Mohamad O, Yu SP, Wei L: Small molecule promoted feeder free and adherent differentiation of functional neurons from human embryonic and induced pluripotent stem cells. J Stem Cells. 2011, 6: 1-7.PubMedGoogle Scholar
  61. Yu PB, Hong CC, Sachidanandan C, Babitt JL, Deng DY, Hoyng SA, Lin HY, Bloch KD, Peterson RT: Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol. 2008, 4: 33-41. 10.1038/nchembio.2007.54.PubMed CentralView ArticlePubMedGoogle Scholar
  62. Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, Hill CS: SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol. 2002, 62: 65-74. 10.1124/mol.62.1.65.View ArticlePubMedGoogle Scholar
  63. Denham M, Dottori M: Signals involved in neural differentiation of human embryonic stem cells. Neurosignals. 2009, 17: 234-241. 10.1159/000231890.View ArticlePubMedGoogle Scholar
  64. Hargus G, Cooper O, Deleidi M, Levy A, Lee K, Marlow E, Yow A, Soldner F, Hockemeyer D, Hallett PJ, Osborn T, Jaenisch R, Isacson O: Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci U S A. 2010, 107: 15921-15926. 10.1073/pnas.1010209107.PubMed CentralView ArticlePubMedGoogle Scholar
  65. Seibler P, Graziotto J, Jeong H, Simunovic F, Klein C, Krainc D: Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells. J Neurosci. 2011, 31: 5970-5976. 10.1523/JNEUROSCI.4441-10.2011.PubMed CentralView ArticlePubMedGoogle Scholar
  66. Caiazzo M, Dell’Anno MT, Dvoretskova E, Lazarevic D, Taverna S, Leo D, Sotnikova TD, Menegon A, Roncaglia P, Colciago G, Russo G, Carninci P, Pezzoli G, Gainetdinov RR, Gustincich S, Dityatev A, Broccoli V: Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature. 2011, 476: 224-227. 10.1038/nature10284.View ArticlePubMedGoogle Scholar
  67. Pfisterer U, Kirkeby A, Torper O, Wood J, Nelander J, Dufour A, Bjorklund A, Lindvall O, Jakobsson J, Parmar M: Direct conversion of human fibroblasts to dopaminergic neurons. Proc Natl Acad Sci U S A. 2011, 108: 10343-10348. 10.1073/pnas.1105135108.PubMed CentralView ArticlePubMedGoogle Scholar
  68. Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C, Ambartsumyan G, Aimiuwu O, Richter L, Zhang J, Khvorostov I, Ott V, Grunstein M, Lavon N, Benvenisty N, Croce CM, Clark AT, Baxter T, Pyle AD, Teitell AD, Pelegrini M, Plath K, Lowry WE: Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell. 2009, 5: 111-123. 10.1016/j.stem.2009.06.008.PubMed CentralView ArticlePubMedGoogle Scholar
  69. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K: Induced pluripotent stem cells generated without viral integration. Science. 2008, 322: 945-949. 10.1126/science.1162494.PubMed CentralView ArticlePubMedGoogle Scholar
  70. Hu BY, Weick JP, Yu J, Ma LX, Zhang XQ, Thomson JA, Zhang SC: Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A. 2010, 107: 4335-4340. 10.1073/pnas.0910012107.PubMed CentralView ArticlePubMedGoogle Scholar
  71. Hirose H, Kato H, Kikuchi-Taura A, Soma T, Taguchi A: Mouse ES cells maintained in different pluripotency-promoting conditions differ in their neural differentiation propensity. In Vitro Cell Dev Biol Anim. 2012, 48: 143-148. 10.1007/s11626-012-9486-z.View ArticlePubMedGoogle Scholar
  72. Sanchez-Danes A, Consiglio A, Richaud Y, Rodriguez-Piza I, Dehay B, Edel M, Bove J, Memo M, Vila M, Raya A, Izpisua Belmonte JC: Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells. Hum Gene Ther. 2011, 23: 56-69.PubMed CentralView ArticlePubMedGoogle Scholar
  73. Theka I, Caiazzo M, Dvoretskova E, Leo D, Ungaro F, Curreli S, Manago F, Dell’Anno MT, Pezzoli G, Gainetdinov RR, Dityatev A, Broccoli V: Rapid generation of functional dopaminergic neurons from human induced pluripotent stem cells through a single-step procedure using cell lineage transcription factors. Stem Cells Transl Med. 2013, 2: 473-479. 10.5966/sctm.2012-0133.PubMed CentralView ArticlePubMedGoogle Scholar
  74. Johnson MA, Weick JP, Pearce RA, Zhang SC: Functional neural development from human embryonic stem cells: accelerated synaptic activity via astrocyte coculture. J Neurosci. 2007, 27: 3069-3077. 10.1523/JNEUROSCI.4562-06.2007.PubMed CentralView ArticlePubMedGoogle Scholar
  75. Wernig M, Zhao JP, Pruszak J, Hedlund E, Fu D, Soldner F, Broccoli V, Constantine-Paton M, Isacson O, Jaenisch R: Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson’s disease. Proc Natl Acad Sci U S A. 2008, 105: 5856-5861. 10.1073/pnas.0801677105.PubMed CentralView ArticlePubMedGoogle Scholar
  76. Schaarschmidt G, Schewtschik S, Kraft R, Wegner F, Eilers J, Schwarz J, Schmidt H: A new culturing strategy improves functional neuronal development of human neural progenitor cells. J Neurochem. 2009, 109: 238-247. 10.1111/j.1471-4159.2009.05954.x.View ArticlePubMedGoogle Scholar
  77. Ullian EM, Sapperstein SK, Christopherson KS, Barres BA: Control of synapse number by glia. Science. 2001, 291: 657-661. 10.1126/science.291.5504.657.View ArticlePubMedGoogle Scholar
  78. Pfrieger FW, Barres BA: Synaptic efficacy enhanced by glial cells in vitro. Science. 1997, 277: 1684-1687. 10.1126/science.277.5332.1684.View ArticlePubMedGoogle Scholar
  79. Tang X, Zhou L, Wagner AM, Marchetto MC, Muotri AR, Gage FH, Chen G: Astroglial cells regulate the developmental timeline of human neurons differentiated from induced pluripotent stem cells. Stem Cell Res. 2013, 11: 743-757. 10.1016/j.scr.2013.05.002.PubMed CentralView ArticlePubMedGoogle Scholar
  80. Wegner F, Kraft R, Busse K, Schaarschmidt G, Hartig W, Schwarz SC, Schwarz J: Glutamate receptor properties of human mesencephalic neural progenitor cells: NMDA enhances dopaminergic neurogenesis in vitro. J Neurochem. 2009, 111: 204-216. 10.1111/j.1471-4159.2009.06315.x.View ArticlePubMedGoogle Scholar
  81. Wegner F, Kraft R, Busse K, Hartig W, Schaarschmidt G, Schwarz SC, Schwarz J, Hevers W: Functional and molecular analysis of GABA receptors in human midbrain-derived neural progenitor cells. J Neurochem. 2008, 107: 1056-1069.PubMedGoogle Scholar
  82. Ge S, Pradhan DA, Ming GL, Song H: GABA sets the tempo for activity-dependent adult neurogenesis. Trends Neurosci. 2007, 30: 1-8. 10.1016/j.tins.2006.11.001.View ArticlePubMedGoogle Scholar
  83. Salazar P, Velasco-Velazquez MA, Velasco I: GABA effects during neuronal differentiation of stem cells. Neurochem Res. 2008, 33: 1546-1557. 10.1007/s11064-008-9642-8.View ArticlePubMedGoogle Scholar

Copyright

© Stanslowsky et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement